Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.30), $0.10 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $4.56 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.